<DOC>
	<DOCNO>NCT02170584</DOCNO>
	<brief_summary>Two substudies assess ( 1 ) tolerability BIBR 953 ZW intravenous infusion 0.1 , 1 5 mg BIBR 953 ZW ( 2 ) absolute bioavailability 100mg BIBR 1048 administer 'acid free ' tablet formulation ( TF1 ) ( 3 ) bioavailability 100 mg tablet BIBR 1048 relative tartaric acid solution 100 mg dose strength ( 4 ) absolute bioavailability 100 mg tartaric acid solution BIBR 1048 MS .</brief_summary>
	<brief_title>Tolerability BIBR 953 ZW IV Bioavailability BIBR 1048 Tablet Solution Healthy Males</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Dabigatran</mesh_term>
	<criteria>Healthy male subject determine result screen Signed write informed consent accordance GCP local legislation Age ≥ 18 ≤ 50 year Broca ≥ 20 % ≤ + 20 % Any find medical examination ( include blood pressure , pulse rate ECG ) deviate normal clinical relevance History current gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunologic , hormonal disorder History orthostatic hypotension , faint spell blackouts Diseases central nervous system ( epilepsy ) psychiatric disorder Chronic relevant acute infection History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator bleed disorder include prolonged habitual bleeding hematologic disease cerebral bleeding ( e.g . car accident ) commotio cerebri Intake drug long halflife ( &gt; 24 hour ) within 1 month prior administration Use drug might influence result trial within 10 day prior administration trial Participation another trial investigational drug within 2 month prior administration trial Smoker ( &gt; 10 cigarette 3 cigar 3 pipes/day ) inability refrain smoke study day Alcohol abuse ( &gt; 60 g/day ) Drug abuse Blood donation within 1 month prior administration trial Excessive physical activity within 5 day prior administration trial Any laboratory value outside clinically accept reference range History familial bleeding disorder Thrombocytes &lt; 150000/µl</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>